Last quarter (Q4 2023), Coya Therapeutics, Inc.'s total revenue was $6.00M, an increase of Infinity% from the same quarter last year. In Q4, Coya Therapeutics, Inc.'s net income was $1.27M. See Coya Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20
Total Revenue	$ 6.00M	-	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	-
Gross Profit	$ 6.00M	-	-	-
Operating Expense	$ 13.91M	$ -9.81M	$ 4.87M	$ 694.77K
Operating Income	$ -7.90M	$ -9.81M	$ -4.87M	$ -694.77K
Net Non Operating Interest Income Expense	-	-	$ 0.00	$ -38.98K
Other Income Expense	$ -639.37K	$ -63.67K	$ -21.48K	$ 550.00
Pretax Income	$ -7.26M	$ -9.75M	$ -4.89M	$ -733.20K
Tax Provision	$ 723.85K	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-
Net Income Common Stockholders	$ -7.99M	$ -12.24M	$ -4.89M	$ -733.20K
Basic EPS	$ -0.79	$ -4.73	$ -1.26	$ -0.19
Diluted EPS	$ -0.79	$ -4.73	$ -1.26	$ -0.19
Basic Average Shares	$ 40.66M	$ 2.59M	$ 3.90M	$ 3.90M
Diluted Average Shares	$ 40.66M	$ 2.59M	$ 3.90M	$ 3.90M
Dividend Per Share	-	-	-	-
Total Operating Income As Reported	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-
Rent Expense Supplemental	-	-	-	-
Total Expenses	$ 13.91M	$ -9.81M	$ 4.87M	$ 694.77K
Net Income From Continuing And Discontinued Operation	$ -7.99M	$ -12.24M	$ -4.89M	$ -733.20K
Normalized Income	$ -1.68M	-	$ -4.89M	$ -733.20K
Interest Expense	-	-	$ 0.00	$ 38.98K
EBIT	$ -7.26M	$ -9.75M	$ -4.87M	$ -694.22K
EBITDA	$ -7.24M	$ -8.72M	$ -4.85M	$ -694.22K

Currency in USD

Coya Therapeutics, Inc. Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing